Concordance With Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 Diabetes
Daniel Edmonston(Duke University), Neha J. Pagidipati(Alnylam Pharmaceuticals (United States)), W. Schuyler Jones(Duke University), Hillary Mulder(Clinical Research Institute), Ashley Goss(Boehringer Ingelheim (United States)), Kelly J. Hunt(Medical University of South Carolina), Wenke Hwang(Penn State Milton S. Hershey Medical Center), Keith Marsolo(Duke University), Raj C. Shah, Javed Butler(University of Mississippi Medical Center), Hayden B. Bosworth(Duke University), Alex R. Chang, Vivian Fonesca(Tulane University), Daniel Fort(Ochsner Health System), Faraz S. Ahmad(Northwestern University), Ajaykumar Rao(Temple University), Adriana M. Hung(Vanderbilt University), Elizabeth Lydon(Duke University), Daniel E. Ford(Johns Hopkins University), Isabelle Ayoub(The Ohio State University Wexner Medical Center), Howard S. Gordon(University of Illinois Chicago), Sriram Machineni, Zachary Lampron(Duke University), Max Pitlosh(Rush University Medical Center), Karen Chiswell(Amyloidosis Foundation)
Cited by 27
Related Papers
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
|Circulation|2020|9.4k
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
|Circulation|2019|9.1k
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k